128 related articles for article (PubMed ID: 3423477)
1. [Alpha-methyl-paratyrosine in the treatment of malignant pheochromocytoma].
Decoulx M; Wemeau JL; Racadot-Leroy N; Grimbert I; Proye C; Plane C
Rev Med Interne; 1987; 8(4):383-8. PubMed ID: 3423477
[TBL] [Abstract][Full Text] [Related]
2. [Effect of alpha-methyl-paratyrosine on the urinary excretion of catecholamines in patients with pheochromocytoma].
Rivero Sánchez M; Selgas Gutiérrez R; Lorenzo Aguiar MD; Martínez Muñoz I; Beberide García JM; Almaraz Jiménez M; Rińon Aguilar C; Sánchez Sicilia L
Rev Clin Esp; 1981 May; 161(4):235-9. PubMed ID: 7280330
[No Abstract] [Full Text] [Related]
3. alpha-Methyl-p-tyrosine: a review of its pharmacology and clinical use.
Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1981 Feb; 21(2):81-9. PubMed ID: 7009139
[TBL] [Abstract][Full Text] [Related]
4. Alternative catecholamine pathways after tyrosine hydroxylase inhibition in malignant pheochromocytoma.
Kuchel O; Buu NT; Edwards DJ
J Lab Clin Med; 1990 Apr; 115(4):449-53. PubMed ID: 1969915
[TBL] [Abstract][Full Text] [Related]
5. Pheochromocytoma: urinary catecholamine excretion and insulin secretion after -methyl-p-tyrosine treatment.
Parra A; Porcayo F; Santos D
Helv Paediatr Acta; 1972 Jul; 27(3):309-14. PubMed ID: 4645656
[No Abstract] [Full Text] [Related]
6. A case of malignant pheochromocytoma treated with 131I-metaiodobenzylguanidine and alpha-methyl-p-tyrosine.
Nakagami Y; Nomura K; Kusakabe K; Miko N; Tsushima T; Demura H
Jpn J Med; 1990; 29(3):329-33. PubMed ID: 1980321
[TBL] [Abstract][Full Text] [Related]
7. Alpha-methyl-p-tyrosine in the symptomatic treatment of patients with malignant phaeochromocytoma.
Pyörälä K; Pitkänen E; Toivonen S
Ann Med Intern Fenn; 1968; 57(2):65-73. PubMed ID: 5706389
[No Abstract] [Full Text] [Related]
8. Malignant pheochromocytoma. Effect of oral alpha-methyl-p-tyrosine upon catecholamine metabolism.
Hengstmann JH; Gugler R; Dengler HJ
Klin Wochenschr; 1979 Apr; 57(7):351-5. PubMed ID: 108462
[TBL] [Abstract][Full Text] [Related]
9. Recurrence of phaeochromocytoma, with development of metastases. Effect of treatment with alpha-methylparatyrosine.
Janssens EN; Krenning EP; Derkx FH
Neth J Med; 1981; 24(3):120-3. PubMed ID: 7254443
[No Abstract] [Full Text] [Related]
10. [A long survived case of malignant pheochromocytoma treated with alpha-methyl-p-tyrosine and midaglizol (DG-5128)].
Okada S; Ohshima K; Onai T; Umahara M; Kobayashi S; Ishihara H
Nihon Gan Chiryo Gakkai Shi; 1990 Jun; 25(6):1221-5. PubMed ID: 1975832
[TBL] [Abstract][Full Text] [Related]
11. Childhood pheochromocytoma: treatment with alpha methyl tyrosine for resistant hypertension.
Robinson RG; DeQuattro V; Grushkin CM; Lieberman E
J Pediatr; 1977 Jul; 91(1):143-7. PubMed ID: 17659
[TBL] [Abstract][Full Text] [Related]
12. Pheochromocytoma resistant to alpha-adrenergic blockade.
Hauptman JB; Modlinger RS; Ertel NH
Arch Intern Med; 1983 Dec; 143(12):2321-3. PubMed ID: 6139989
[TBL] [Abstract][Full Text] [Related]
13. [Metastatic malignant pheochromocytoma: treatment with alpha-methyl-para-tyrosine].
Tcherdakoff P; Ménard J; Bedrossian J; Vaysse J; Alexandre JM; Milliez P
Sem Hop; 1972 May; 48(25):1779-87. PubMed ID: 4405188
[No Abstract] [Full Text] [Related]
14. Phaeochromocytoma with myocarditis managed with alpha-methyl-p-tyrosine.
Begnall WE; Salway JG; Jackson EW
Postgrad Med J; 1976 Oct; 52(612):653-6. PubMed ID: 995792
[TBL] [Abstract][Full Text] [Related]
15. Adrenergic blockade in pheochromocytoma.
Modlinger RS; Ertel NH; Hauptman JB
Arch Intern Med; 1983 Dec; 143(12):2245-6. PubMed ID: 6139986
[No Abstract] [Full Text] [Related]
16. Surgical management of pheochromocytoma with the use of metyrosine.
Perry RR; Keiser HR; Norton JA; Wall RT; Robertson CN; Travis W; Pass HI; Walther MM; Linehan WM
Ann Surg; 1990 Nov; 212(5):621-8. PubMed ID: 1978640
[TBL] [Abstract][Full Text] [Related]
17. [Hypotension, mental disorders and changes in catecholamine excretion observed during the administration of disulfiram in a case of pheochromocytoma].
Serrano PA; Hava-Kuri I; Chávez-Lara B; Cervantes-Osorio L; Zaldivar HM
Arch Inst Cardiol Mex; 1978; 48(2):437-43. PubMed ID: 666450
[TBL] [Abstract][Full Text] [Related]
18. Three cases of malignant pheochromocytoma treated with cyclophosphamide, vincristine, and dacarbazine combination chemotherapy and alpha-methyl-p-tyrosine to control hypercatecholaminemia.
Tada K; Okuda Y; Yamashita K
Horm Res; 1998; 49(6):295-7. PubMed ID: 9623522
[TBL] [Abstract][Full Text] [Related]
19. Alpha-methyl-p-tyrosine in the management of phaeochromocytoma.
Jones NF; Walker G; Ruthven CR; Sandler M
Lancet; 1968 Nov; 2(7578):1105-9. PubMed ID: 4177160
[No Abstract] [Full Text] [Related]
20. Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a pheochromocytoma.
Imperato-McGinley J; Gautier T; Ehlers K; Zullo MA; Goldstein DS; Vaughan ED
N Engl J Med; 1987 Mar; 316(13):793-7. PubMed ID: 2881206
[No Abstract] [Full Text] [Related]
[Next] [New Search]
